Navigation Links
Jefferson receives $3 million NIH grant to study molecular and genetic mechanisms in platelets
Date:8/27/2010

telet function. This may serve as a biomarker to predict who might be at risk for bleeding or clotting in different clinical settings and to predict who may benefit from specific drug therapies."

The study will be conducted at two centers: Thomas Jefferson University and Baylor-College of Medicine in Houston. 180 healthy patients over the age of 18 will be selected and prescreened for any potential drug interaction that may skew the results.

"This is a little different from traditional clinical studies in that we are looking for healthy, medication-free patients," said Bray. "Invariably hospitalized patients are receiving multiple medications that may alter platelet function and distort the results. Therefore, we will do extensive pre-enrollment screening. Fortunately, it is fairly easy to find large numbers of eligible volunteers at large medical centers like Jefferson and Baylor College of Medicine."


'/>"/>

Contact: Rick Cushman
richard.cushman@jefferson.edu
215-955-2240
Thomas Jefferson University
Source:Eurekalert

Page: 1 2

Related biology news :

1. Jefferson scientists deliver toxic genes to effectively kill pancreatic cancer cells
2. Jefferson Department of Surgery announces new pancreas tumor registry
3. Jefferson scientists discover a key protein regulator of inflammation and cell death
4. Jefferson researcher awarded Landenberger Foundation grant for ALS research
5. Jefferson receives $1.7 million grant to study stem cells in intervertebral discs of the spine
6. US Department of State names UCR entomologist a Jefferson Science Fellow
7. Jefferson scientists identify a new protein involved in longevity
8. Wistar Institute researcher receives New Innovator award from NIH
9. L-1 Identity Solutions Receives $5.9 Million Drivers License Contract Expansion from the State of Mississippi
10. Kount Receives Patent for Device Fingerprinting
11. American College of Medical Genetics receives $13.5M NIH contract
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/14/2015)... , April 14, 2015 NXT-ID, Inc. (NASDAQ: ... authentication company focused on the growing mobile commerce market, ... for the 2015 New York Design Awards under the ... New York City Design Awards are part of a ... over 2,500 ratings from the marketplace, industry and judging ...
(Date:4/9/2015)... SAN JOSE, Calif. , April 9, 2015 /PRNewswire/ ... of human interface solutions, announced today that it will ... 2015 on Thursday, April 23, 2015, after the close ... call for analysts and investors at 2:00 p.m. PT ... information.    To participate on the live ...
(Date:4/2/2015)... Md. , April 2, 2015 At ... Salt Lake City , the American College ... of five new directors to its Board.  Members of ... the ACMG and for forming and advancing its policies ... medical genetics profession. "It,s an eventful time ...
Breaking Biology News(10 mins):NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 2NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 3Synaptics to Report Third Quarter Results on April 23 2American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 2American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 3American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 4American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 5American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 6American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 7American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 8
... in German . Medicines from plants ... However, that has nothing in common with what the ... Applied Ecology IME in Aachen, Germany, are doing. They ... unlike many other medications, cannot be chemically produced. ...
... ,A pan-European study of 755 gout patients found that prevalence ... lowest in France (0.76%). French, German and British gout patients ... work and social impairment compared to controls (p , Abstract ... efficacy and safety of pegloticase (Krystexxa) , Results of ...
... that the HPV vaccine did not have significant effects on ... with inactive SLE receiving stable doses of medications after administration, ... in this group of patients. SLE, an autoimmune disorder, affects ... shown that the rate of HPV in this group is ...
Cached Biology News:Medicines from plants 2Several abstracts on gout reveal true burden of disease and highlight promising new treatments 2Study shows the HPV vaccine Gardasil doesn't increase disease activity in SLE patients 2
(Date:4/23/2015)... Prospects for Leading Companies in ... Details   We predict the global healthcare ... in 2015 and will grow at a CAGR of 6.3% ... around the world and increasing functional requirements for healthcare packaging ... global healthcare packaging market. A global ageing population, ...
(Date:4/23/2015)... April 23, 2015  Metanome, Inc., an industry ... company has changed its name to Diversigen, Inc.  ... as the single commercial source for the myriad ... on the diverse opportunities of the microbiome.  From ... accepts – including those that are difficult to ...
(Date:4/23/2015)... April 23, 2015 ReliantHeart's HeartAssist5® Ventricular ... (blood flow through the device) in real time, and ... the world’s leading provider of Machine to Machine (M2M) ... True Flow via VADLink.com can be monitored ... any drop in flow below a minimum threshold, the ...
(Date:4/22/2015)... 2015  Sangamo BioSciences, Inc. (NASDAQ: SGMO ) ... accomplishments. For the first quarter ended March ... $5.3 million, or $0.08 per share, compared to a ... for the same period in 2014. As of March ... securities and interest receivable of $226.1 million. ...
Breaking Biology Technology:Healthcare Packaging Market Forecast 2015-2025 2Healthcare Packaging Market Forecast 2015-2025 3Healthcare Packaging Market Forecast 2015-2025 4Healthcare Packaging Market Forecast 2015-2025 5Healthcare Packaging Market Forecast 2015-2025 6Healthcare Packaging Market Forecast 2015-2025 7Healthcare Packaging Market Forecast 2015-2025 8Healthcare Packaging Market Forecast 2015-2025 9Healthcare Packaging Market Forecast 2015-2025 10Metanome Announces Corporate Name Change to Diversigen 2Sangamo BioSciences Reports First Quarter 2015 Financial Results 2Sangamo BioSciences Reports First Quarter 2015 Financial Results 3Sangamo BioSciences Reports First Quarter 2015 Financial Results 4Sangamo BioSciences Reports First Quarter 2015 Financial Results 5Sangamo BioSciences Reports First Quarter 2015 Financial Results 6Sangamo BioSciences Reports First Quarter 2015 Financial Results 7Sangamo BioSciences Reports First Quarter 2015 Financial Results 8
... Fla., Aug. 7 Catalyst Pharmaceutical Partners, Inc. (Nasdaq: CPRX ) ... 30, 2009. , , Second Quarter 2009 ... 30, 2009, the Company reported a net loss of $1,761,887, or $0.13 per ... per basic and diluted share for the same period in 2008. Second quarter ...
... , BRISBANE, Calif., Aug. 7 InterMune, Inc. (Nasdaq: ... Executive Officer and President of InterMune, will present at the Canaccord ... 2009 at 10:30 a.m. EDT. , , To ... interested parties may log on to the investor relations page of ...
... , , , ... Genetics (Pink Sheets: VRAL) has formed a wholly owned subsidiary ... technology developed by University of Colorado Professor M. Karen Newell ... tumor cell,s ability to generate energy from glucose or from ...
Cached Biology Technology:Catalyst Pharmaceutical Partners Reports Second Quarter 2009 Financial Results 2Catalyst Pharmaceutical Partners Reports Second Quarter 2009 Financial Results 3Catalyst Pharmaceutical Partners Reports Second Quarter 2009 Financial Results 4Catalyst Pharmaceutical Partners Reports Second Quarter 2009 Financial Results 5Catalyst Pharmaceutical Partners Reports Second Quarter 2009 Financial Results 6Catalyst Pharmaceutical Partners Reports Second Quarter 2009 Financial Results 7Viral Genetics Creates Subsidiary to Develop Cancer Therapy 2Viral Genetics Creates Subsidiary to Develop Cancer Therapy 3Viral Genetics Creates Subsidiary to Develop Cancer Therapy 4
Glutathione Agarose Beads 10 ml...
...
...
Rabbit monoclonal [EP881Y] to EEF2K ( Abpromise for all tested applications). Antigen: Synthetic peptide corresponding to residues in the C-terminal of human EEF2K. Entrez GeneID: 29904 S...
Biology Products: